Menu Search
Equities

ECS Botanics Holdings Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
ECS:ASX

ECS Botanics Holdings Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (AUD)0.006
  • Today's Change0.00 / 0.00%
  • Shares traded333.68k
  • 1 Year change-57.14%
  • Beta1.2952
Data delayed at least 20 minutes, as of Mar 02 2026 04:11 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

ECS Botanics Holdings Ltd is an Australia-based medicinal cannabis cultivator and manufacturer located in Northwest Victoria. The Company utilizes progressive and cultivation methodologies to produce medicine in a sustainable way, adopting regenerative and organic horticultural practices and renewable energy sources. The Company is a producer and supplier of affordable, premium-grade medicinal cannabis. The Company services both the Australian market and key international markets. It specializes in cultivating cannabis, which after drying and curing, is supplied as a trimmed flower for inhalation, or extracted into resin for further formulation or manufacturing.

  • Revenue in AUD (TTM)19.48m
  • Net income in AUD-5.73m
  • Incorporated1970
  • Employees220.00
  • Location
    ECS Botanics Holdings LtdSe 2 L 1, 1 Altona StPERTH 6005AustraliaAUS
  • Phone+61 86559-1792
  • Fax+61 30088-6783
  • Websitehttps://ecs-botanics.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.